Jean-Claude Maurel

This profile gathers the share dealings of Jean-Claude Maurel in Medesis Pharma S.A., where the filings describe the role as chief executive. We count 11 filings; the first trade dates from 9 April 2021 and the latest from 21 November 2024.

Every open-market trade on record is a sale: 10 sales worth €69k. In 2024 alone, the filings show no purchases and 3 sales.

The newest entry dates from 3 December 2024: an open-market sale of €4,142, in Medesis Pharma S.A. Between a trade and the moment it shows up on AMF, the median delay is 12 days. For comparison, MAR article 19 gives managers three business days to notify a trade. A sale on its own says little: insiders also sell to pay tax, fund a purchase or diversify. Every figure here comes from the filings published by AMF and describes the past, not future prices; it is not investment advice.